Denise Anderson

This is still a very new area will that continue to grow. At some point, we won't differentiate between these read more

This is still a very new area will that continue to grow. At some point, we won't differentiate between these drugs.

These numbers prove once again the real power of a strong oncology franchise.

These numbers prove once again the real power of a strong oncology franchise.

It's a frustration that these letters aren't considered public and so it's difficult to understand what the risks are.

It's a frustration that these letters aren't considered public and so it's difficult to understand what the risks are.

The technology is in a very early stage in general, so it may in the future provide breakthroughs but in read more

The technology is in a very early stage in general, so it may in the future provide breakthroughs but in the short-term it is certainly going to take time.

Roche is one of the most outstanding companies in the pharmaceutical industry in our view.

Roche is one of the most outstanding companies in the pharmaceutical industry in our view.